Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hemodialysis I: Introduction

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...

Healthcare Associated Infections II: Preventive Measures

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

Hemodialysis II: Procedure and Complications

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...

Hemodialysis III: Nursing Management

Hemodialysis III: Nursing Management

The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this measurement...

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...

Dialysis

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The Supreme Court ruling on the meaning of 'woman' and the implications for trans people.

British journal of nursing (Mark Allen Publishing)·2026

Same author

Managing Kidney Disease in the Trans Community.

Journal of renal care·2025

Same author

Sexual orientation and gender identity (SOGI) and electronic health record data, a mechanism for gender-affirming care and evidence-based practice for sexual and gender minority healthcare - Response to Ginaldi et al.

Intensive & critical care nursing·2024

Same author

Caring for Transgender patients in the ICU: Current insights for equitable care.

Intensive & critical care nursing·2024

Same author

Ethical considerations for the nursing care of Transgender patients in the Intensive Care Unit.

Nursing in critical care·2024

Same author

Authentic allyship for gender minorities.

Journal of nursing scholarship : an official publication of Sigma Theta Tau International Honor Society of Nursing·2023

Search research articles

Related Experiment Video

Updated: Jun 1, 2026

A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit

A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit

Published on: July 13, 2019

Reducing haemodialysis access infection rates.

Amanda Dorman¹, Marissa Dainton

¹Dunkirk Renal Satellite Unit, Dover and Marissa Dainton.

British Journal of Nursing (Mark Allen Publishing)

|June 8, 2011

Summary

Healthcare-associated infections (HCAIs) are a significant cause of vascular access loss in haemodialysis patients. This study examines strategies and products like Chloraprep to reduce infection risks in renal care.

Area of Science:

Nephrology
Infectious Diseases
Healthcare Management

Background:

Infections represent the second leading cause of vascular access loss in long-term haemodialysis patients.
Healthcare-associated infections (HCAIs) linked to vascular access have increased, prompting focused interventions.
Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections are a key concern in England, driving improvements in vascular access care.

Purpose of the Study:

To review the drivers and strategies aimed at reducing vascular access infections in haemodialysis.
To highlight the role of evidence-based guidelines and product development in infection control.
To discuss the application of specific antiseptic products, such as Chloraprep, within the NHS.

Main Methods:

More Related Videos

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

Related Experiment Videos

Last Updated: Jun 1, 2026

A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit

A Protocol to Set Up Needle-Free Connector with Positive Displacement on Central Venous Catheter in Intensive Care Unit

Published on: July 13, 2019

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

Review of publication guidelines and local protocols for infection prevention.

Analysis of root cause assessments for vascular access infections.

Examination of manufacturer-developed products designed to minimize infection risk.

Main Results:

Publication guidelines and local protocols provide evidence-based recommendations to reduce infection risk.
Root cause analyses identify areas for practice improvement in vascular access care.
Product development by manufacturers supports infection reduction efforts.

Conclusions:

Implementing evidence-based practices and utilizing advanced products are crucial for reducing vascular access infections.
Targeted interventions, driven by clinical outcomes like MRSA infections, have improved care standards.
Products like Chloraprep are utilized within the National Health Service (NHS) to mitigate infection risks in haemodialysis patients.